Chemotherapy Treatment Costs and Clinical Outcomes of Colon Cancer in the U.S. Military Health System’s Direct and Private Sector Care Settings
Abstract
Identifying low-value cancer care may be an important step in containing costs associated with treatment. Low-value care occurs when the medical services, tests, or treatments rendered do not result in clinical benefit. These may be impacted by care setting and patients’ access to care and health insurance. We aimed to study chemotherapy treatment and the cost paid by the Department of Defense (DoD) for treatment in relation to clinical outcomes among patients with colon cancer treated within the U.S. Military Health System’s direct and private sector care settings to better understand the value of cancer care.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 11, 2023
- Source ID
- 10.1093/milmed/usad132
Entities
People
- Craig D Shriver
- Jerry S. H. Lee
- Kangmin Zhu
- Mayada Aljehani
- Seth A. Seabury
- Tracey Koehlmoos
- Yvonne L Eaglehouse
Organizations
- F. Edward Hébert School of Medicine
- Henry M. Jackson Foundation for the Advancement of Military Medicine
- Uniformed Services University of the Health Sciences
- University of Southern California